Johnson & Johnson
JNJ
$204.75
$2.141.05%
NYSE
| 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/29/2024 | 09/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.77% | 5.77% | 2.39% | 5.26% | 5.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.77% | 5.77% | 2.39% | 5.26% | 5.25% |
| Cost of Revenue | 7.90% | 10.86% | 11.45% | 6.03% | 5.91% |
| Gross Profit | 6.29% | 3.53% | -1.58% | 4.92% | 4.96% |
| SG&A Expenses | 10.11% | 5.60% | -0.92% | 11.90% | 2.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.27% | 7.15% | 2.53% | 11.31% | 13.31% |
| Operating Income | 31.53% | 2.52% | 2.03% | -15.47% | -13.67% |
| Income Before Tax | 124.48% | 12.93% | 267.02% | -19.46% | -36.02% |
| Income Tax Expenses | 263.51% | -10.17% | 473.42% | -34.29% | -29.07% |
| Earnings from Continuing Operations | 91.24% | 18.16% | 237.91% | -16.97% | -37.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 91.24% | 18.16% | 237.91% | -15.26% | -89.65% |
| EBIT | 31.53% | 2.52% | 2.03% | -15.47% | -13.67% |
| EBITDA | 22.68% | 3.89% | 1.05% | -4.96% | -10.41% |
| EPS Basic | 91.16% | 18.18% | 238.06% | -3.41% | -89.15% |
| Normalized Basic EPS | 19.39% | -2.22% | 3.99% | -17.96% | -4.91% |
| EPS Diluted | 90.99% | 18.65% | 238.81% | -3.38% | -89.13% |
| Normalized Diluted EPS | 19.41% | -2.13% | 4.22% | -17.96% | -4.73% |
| Average Basic Shares Outstanding | 0.05% | -0.02% | -0.04% | -12.27% | -4.59% |
| Average Diluted Shares Outstanding | 0.03% | -0.12% | -0.26% | -12.27% | -4.78% |
| Dividend Per Share | 4.84% | 4.84% | 4.20% | 4.20% | 4.20% |
| Payout Ratio | -0.45% | -0.11% | -0.69% | 0.23% | -- |